Traws Pharma, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Traws Pharma, Inc. (TRAW) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $15.66 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-04-15
- Traws Pharma, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $15.66M.
- Traws Pharma, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$161.83M.
- Traws Pharma, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$18.95M.
- Traws Pharma, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$18.98M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $15.66M 10-K · filed 2026-04-15 |
| 2024-12-31 | -$161.83M 10-K · filed 2026-04-15 |
| 2023-12-31 | -$18.95M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$18.98M 10-K · filed 2024-04-01 |
| 2021-12-31 | -$16.15M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$25.17M 10-K · filed 2022-03-21 |
| 2019-12-31 | -$21.53M 10-K · filed 2021-03-18 |
| 2018-12-31 | -$20.58M 10-K · filed 2020-03-27 |
| 2017-12-31 | -$24.13M 10-K · filed 2019-04-01 |
| 2016-12-31 | -$19.74M 10-K · filed 2018-03-16 |
| 2015-12-31 | -$24.06M 10-K · filed 2017-03-29 |
| 2014-12-31 | -$63.91M 10-K · filed 2016-03-28 |
| 2013-12-31 | -$62.15M 10-K · filed 2015-03-30 |
| 2012-12-31 | -$29.91M 10-K · filed 2015-03-30 |
| 2011-12-31 | -$26.29M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |